Bruker Energy & Supercon Technologies, Inc. Files Registration Statement for Initial Public Offering

Energy & Supercon Technologies, Inc. Files Registration Statement for

Initial Public Offering

Massachusetts, September 3, 2010 Bruker Corporation ( Bruker ) (NASDAQ: BRKR),

a leading global provider of high-performance scientific instruments, and

Bruker Energy & Supercon Technologies, Inc. ( BEST ), a leading provider of

superconducting technology and enabling tools and a Bruker subsidiary, today

announced that BEST has filed a Form S-1 Registration Statement with the United

States Securities and Exchange Commission relating to the proposed initial

public offering (the offering ) of common stock of BEST. The offering may include shares offered by

Bruker as a selling stockholder. The number of shares to be offered by BEST and

by Bruker and the price range for the offering have not yet been determined.

Bruker intends to retain a controlling equity interest in BEST for the

registration statement relating to the common stock to be sold in the offering

has been filed with the Securities and Exchange Commission but has not yet

become effective. These securities may not be sold nor any offers to buy be

accepted prior to the time the registration statement becomes effective. This

news release shall not constitute an offer to sell or the solicitation of an

offer to buy, nor shall there be any sale of these securities in any state in

which such an offer, solicitation or sale would be unlawful prior to

registration or qualification under the securities laws of any such state.

& Company, Inc. and UBS Investment Bank are acting as joint book-running

managers for the offering. Needham & Company, LLC is acting as lead manager

and Gleacher & Company Securities, Inc. is acting as co-manager for the

offering is only being made by means of a prospectus. When available, copies of

the preliminary prospectus may be obtained by contacting: Jefferies &

Company, Inc., 520 Madison Avenue, New York, NY 10022, Attention: Syndicate

Prospectus Department, (888) 449-2342; and UBS Investment Bank, 299 Park

Avenue, New York, NY 10171, Attention: Prospectus Department, (888) 827-7275.

release contains forward-looking statements as defined under the U.S. federal

securities laws including, but not limited to, statements regarding BEST s

intention to conduct an offering of its common stock and that Bruker may sell a

portion of its BEST shares in the offering.

Actual events could differ materially from those anticipated in the

forward-looking statements as a result of certain factors, including but not

limited to adverse changes in general economic or market conditions, the

inability to manage successfully and complete the offering, the risk that the

offering of BEST may not occur in its expected timeframe or at all, and other

important factors disclosed previously and from time to time in Bruker s

filings with the U.S. Securities and Exchange Commission. Bruker disclaims any obligation to update any

such forward-looking statements after the date of this release.